Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Medicure (MCUJF) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Medicure (MCUJF) over the last 17 years, with Q3 2025 value amounting to $3.3 million.

  • Medicure's Change in Receivables rose 365496.89% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year increase of 586546.25%. This contributed to the annual value of $3.8 million for FY2024, which is 770.17% up from last year.
  • Medicure's Change in Receivables amounted to $3.3 million in Q3 2025, which was up 365496.89% from $3.7 million recorded in Q2 2025.
  • In the past 5 years, Medicure's Change in Receivables registered a high of $4.7 million during Q2 2022, and its lowest value of -$1.1 million during Q1 2022.
  • Over the past 5 years, Medicure's median Change in Receivables value was $302992.1 (recorded in 2023), while the average stood at $985177.2.
  • Its Change in Receivables has fluctuated over the past 5 years, first plummeted by 34065.02% in 2022, then soared by 3575306.52% in 2025.
  • Over the past 5 years, Medicure's Change in Receivables (Quarter) stood at $50773.5 in 2021, then surged by 8076.15% to $4.2 million in 2022, then crashed by 92.46% to $312912.1 in 2023, then soared by 33.37% to $417340.1 in 2024, then surged by 684.87% to $3.3 million in 2025.
  • Its Change in Receivables stands at $3.3 million for Q3 2025, versus $3.7 million for Q2 2025 and $3.1 million for Q1 2025.